Response to Subsequent SEC Comment Letter

27th May 09

Release Date: 27/05/2009 12:00am

Pharmaxis initially responded to SEC comments on the 2008 Annual Report on Form 20-F on 27 March 2009. The SEC then commented on the Pharmaxis initial response in a subsequent comment letter. The Pharmaxis response to this subsequent comment letter is attached

 

View PDF

Categories: Sec Filings